机构名称：
¥ 4.0
iPSC-derived Cell Therapy Products: ➢ Well-characterized, uniform in composition, consistent production of drug product ➢ Low cost of goods and not susceptible to donor-to-donor variability ➢ Monoclonal antibody-like treatment: on-demand availability, repeat dosing, ease of combinability ➢ Patient convenience and reach: off-the-shelf, reduced toxicities, reduced hospitalization, community setting
编程的细胞免疫疗法
主要关键词
相关文件推荐
